Skip to main content
Log In
Sign Up
Home
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Technical Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Watchlist
Collapse
Innovent Biologics, Inc. (IVBIY)
OTCMKTS
· Delayed Price · Currency is USD
Watchlist
Compare
51.09
0.00 (0.00%)
At close: Sep 25, 2025
Overview
Financials
Statistics
History
Profile
Chart
Income
Balance Sheet
Cash Flow
Ratios
KPIs
NEW
Annual
Revenue by Product
Fiscal year is January - December.
Download
Full Width
Year Ending
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
Dec '20
Dec 31, 2020
2017 - 2019
Antibody and Protein Medicine, Pharmaceutical Products and Consultation and Research and Development Services
10.22B
Log In
Log In
Log In
Log In
Upgrade
Antibody and Protein Medicine, Pharmaceutical Products and Consultation and Research and Development Services Growth
48.96%
Log In
Log In
Log In
Log In
Upgrade
Revenue by Geography
Fiscal year is January - December.
Download
Full Width
Year Ending
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
Dec '20
Dec 31, 2020
2017 - 2019
China
9.74B
Log In
Log In
Log In
Log In
Upgrade
China Growth
53.21%
Log In
Log In
Log In
Log In
Upgrade
United States
446.26M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-8.75%
Log In
Log In
Log In
Log In
Upgrade
Other
29.14M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
160.50%
Log In
Log In
Log In
Log In
Upgrade
France
-
Log In
Log In
Log In
Log In
Upgrade
